Abstracts tagged "Synovial Immune Biology and ultrasound"

Abstract Number: 1997 • 2019 ACR/ARP Annual Meeting
Histologic and Clinical Correlates of Ultrasound Measures of Joint Inflammation: Analysis of RA Tissue Obtained by Ultrasound Guided Biopsy in Phase 2 of the Accelerating Medicines Partnership RA Network
Diane Horowitz¹, Andrew Filer ², Jennifer Albrecht ³, Arthur Mandelin ⁴, Darren Tabechian ⁵, Edward DiCarlo ⁶, Brendan Boyce ³, Ellen Gravallese ⁷, Peter Gregersen ⁸, Dagmar Scheel-Toellner ⁹, Kevin Wei ¹⁰, Katherine Liao ¹¹, Larry Moreland ¹², V. Michael Holers ¹³, Michael Brenner ¹⁴, Jennifer Anolik ³ and Vivian Bykerk ¹⁵, ¹Northwell Health, Great Neck, NY, ²Institute of Inflammation and Ageing College of Medical and Dental Sciences University of Birmingham, Birmingham, United Kingdom, ³University of Rochester Medical Center, Rochester, NY, ⁴Northwestern University Feinberg School of Medicine, Division of Rheumatology, Chicago, IL, ⁵University of Rochester, Rochester, NY, ⁶Hospital for Special Surgery, New York, ⁷University of Massachusetts Medical School, Worcester, MA, ⁸Feinstein Institutes for Medical Research, Manhasset, NY, ⁹University of Birmingham, Birmingham, United Kingdom, ¹⁰Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ¹¹Brigham and Women's Hospital, Boston, ¹²University of Pittsburgh, PITTSBURGH, PA, ¹³University of Colorado Denver, Division of Rheumatology, Aurora, CO, USA, Denver, ¹⁴Brigham and Women’s Hospital:, Boston, ¹⁵Hospital for Special Surgery, New York City, NY
Background/Purpose: The AMP-RA network applies cutting edge molecular single cell technologies to study synovial tissue obtained from rheumatoid arthritis (RA) patients using US guided synovial…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].